p53基因Msp I位点多态性与NSCLC易感性及辐射敏感性关系的研究
目的研究中国北方人对非小细胞肺癌(NSCLC)的易感性及放疗敏感性与p53基因Msp I单核苷酸多态性(SNP)的关系。方法采用病例对照方法,通过合成序列特异性引物(PCR-RFLP)方法检测50例NSCLC患者及56例健康对照者的p53基因Msp I单核苷酸多态性位点的基因型。同时,观察不同基因型患者的放射治疗疗效,检测与辐射敏感性相关的基因型。结果NSCLC组的A1/A2杂和基因型频率明显高于对照组(χ2=4.38 ...
马忠余 +4 more
doaj
[Research Progress on Interleukin-6 in Screening and Prognosis of Patients with Non-small Cell Lung Cancer]. [PDF]
Xu D, Qiao C, Zhang X, Kong Q, Ji X.
europepmc +1 more source
[Advances in Targeted Therapy for Advanced Non-small Cell Lung Cancer with HER2 Mutation]. [PDF]
Yu J, Cao B.
europepmc +1 more source
[Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib]. [PDF]
Yu J, Ren S.
europepmc +1 more source
[Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer]. [PDF]
Yang X, Tang Z, Ma L, Chen R.
europepmc +1 more source
[Research Progress and Challenges of Oligometastasis in Non-small Cell Lung Cancer]. [PDF]
Li S, Shao T, Yao S.
europepmc +1 more source
A Case Report of Erlotinib as First-line Therapy in Extensive Metastatic Patient with Advanced Non-small Cell Lung Cancer [PDF]
Wanfeng GUO, Xiaoqing LIU
core
[Advances in Diagnosis and Targeted Therapy of KRASG12C Mutant Non-small Cell Lung Cancer]. [PDF]
Shi J, Wang Y, Zheng J, Zhou J.
europepmc +1 more source
[Advances in Antibody-drug Conjugates for Non-small Cell Lung Cancer after Resistance to First-line Therapy]. [PDF]
Li H, Jing Y, Sun J, Xu J, Li Y.
europepmc +1 more source

